LADENBURG THALMANN FINANCIAL SERVICES INC. - OPIANT PHARMACEUTICALS INC ownership

OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 28 filers reported holding OPIANT PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of OPIANT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$9,0000.0%5750.0%0.00%
Q3 2019$9,000
+28.6%
5750.0%0.00%
Q2 2019$7,000
-12.5%
575
-14.8%
0.00%
Q1 2019$8,000
-20.0%
6750.0%0.00%
Q4 2018$10,000
-16.7%
6750.0%0.00%
Q3 2018$12,000
+33.3%
675
+48.4%
0.00%
Q2 2018$9,0000.0%4550.0%0.00%
Q1 2018$9,000
-10.0%
4550.0%0.00%
Q4 2017$10,000
-9.1%
455
+49.2%
0.00%
Q3 2017$11,0003050.00%
Other shareholders
OPIANT PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
HealthInvest Partners AB 210,000$2,518,0005.80%
APIS CAPITAL ADVISORS, LLC 196,000$2,350,0002.65%
Stonepine Capital Management, LLC 152,278$1,826,0000.85%
Parkman Healthcare Partners LLC 75,632$907,0000.33%
PERRITT CAPITAL MANAGEMENT INC 30,500$366,0000.22%
ESSEX INVESTMENT MANAGEMENT CO LLC 50,405$604,0000.10%
ACADIAN ASSET MANAGEMENT LLC 126,978$1,523,0000.01%
Trexquant Investment LP 12,219$147,0000.01%
Renaissance Technologies 193,415$2,319,0000.00%
TWO SIGMA ADVISERS, LP 74,400$892,0000.00%
View complete list of OPIANT PHARMACEUTICALS INC shareholders